Supranuclear Palsy, Progressive: all 171 studies
Page 1 of 2. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of NIO752 in Primary TauopathiesNot yet recruitingNCT07868328Phase 2
- Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual TrialRecruitingNCT07863180Phase 1/2
- Wellness in PSP and CBDRecruitingNCT07844655Not applicable
- VisMemoPD Protocol: an Observational Pilot Study on Spatial and Topographical Memory in Patients With Parkinson's Disease and ParkinsonismNot yet recruitingNCT07827963
- Study Evaluating the Effect of Transcranial Direct Current Stimulation (tDCS) Targeting the Right Inferior Frontal Gyrus on Inhibitory Control in Patients With PSPNot yet recruitingNCT07818733Not applicable
- Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH)RecruitingNCT07805967
- Biofluid Research on Age-Related or Inherited NeurodegenerationRecruitingNCT07798700
- Early Molecular Biomarkers for Differentiating Parkinsonian SyndromesEnrolling by invitationNCT07604883
- Individualized Transcranial Magnetic Stimulation in Parkinsonian DisordersRecruitingNCT07570212Not applicable
- Tracking and Predicting How Brain Damage Spreads in Neurodegenerative DiseasesEnrolling by invitationNCT07567664Not applicable
- Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic DisordersRecruitingNCT07509125Not applicable
- A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear PalsyRecruitingNCT07498426Phase 3
- Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital BiomarkersRecruitingNCT07392411
- Study to Evaluate the Feasibility of Syde® Digital Endpoints for Monitoring Patients With Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R)Not yet recruitingNCT07389018
- tDCS as Treatment for Motor FunctionRecruitingNCT07291687Not applicable
- The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31Enrolling by invitationNCT07264283Phase 2
- Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy BodiesNot yet recruitingNCT07240805
- Trial of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease or Primary TauopathiesRecruitingNCT07221344Phase 1/2
- The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1Enrolling by invitationNCT07217665Phase 2
- The Progressive Supranuclear Palsy Clinical Trial PlatformRecruitingNCT07173803Phase 2
- Collection of Digital Parameters From Parts of the Neurological Examination Using an Eye TrackerNot yet recruitingNCT07141719
- Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic PathologyRecruitingNCT07136844Not applicable
- AI-Enhanced Optimization of Acute Levodopa Challenge TestRecruitingNCT06949865
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183ARecruitingNCT06932809Early Phase 1
- The CurePSP Genetics ProgramRecruitingNCT06647641
- Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian SyndromesRecruitingNCT06645626
- Parkinson Atypical Rating of Oculometric Patterns Evaluated RoutinelyEnrolling by invitationNCT06597071Not applicable
- Neurodegenerative Diseases Progression Markers (MARKERS-NDD)RecruitingNCT06596746
- Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative ModelingRecruitingNCT06529744
- NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian SyndromeRecruitingNCT06490926
- NYSCF Scientific Discovery BiobankRecruitingNCT06203106
- The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related DisordersRecruitingNCT06174948Not applicable
- The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical ParkinsonismRecruitingNCT06162013Phase 2
- Early Biomarkers of Neurodegeneration in Parkinsonian SyndromesNot yet recruitingNCT06155942Not applicable
- Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian PatientsRecruitingNCT05139342Not applicable
- Synaptic Loss in Multiple System AtrophyRecruitingNCT05121012
- Remote Monitoring in Progressive Supranuclear Palsy (PSP)Not yet recruitingNCT04753320
- UPenn Observational Research Repository on Neurodegenerative DiseaseRecruitingNCT04715399
- Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative DiseasesRecruitingNCT04706234
- Neurodegenerative Diseases RegistryRecruitingNCT04472130
- Transcranial Magnetic Stimulation in Progressive Supranuclear PalsyRecruitingNCT04468932Not applicable
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)RecruitingNCT04363684
- Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using NeuroimagingRecruitingNCT03872102
- Quality of Life of the Patient and the Burden of the Caregiver in Progressive Supranuclear PalsyRecruitingNCT03638505
- Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal DementiaRecruitingNCT03225144
- The Swedish BioFINDER 2 StudyRecruitingNCT03174938Not applicable
- Diagnosing Frontotemporal Lobar DegenerationRecruitingNCT02964637
- Neurologic Stem Cell Treatment StudyRecruitingNCT02795052Not applicable
- A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear PalsyRecruitingNCT02605785Not applicable
- Modifiable Variables in Parkinsonism (MVP)RecruitingNCT02194816
- Biomarkers in Parkinsonian SyndromesRecruitingNCT02114242
- GV1001 Subcutaneous(SC) for the Treatment of Progressive Supranuclear Palsy (PSP)CompletedNCT05819658Phase 2Results posted
- A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese PatientsCompletedNCT04193527Phase 3Results posted
- In-Home Care for Patients With PSP and Related DisordersCompletedNCT03552484Not applicableResults posted
- An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)TerminatedNCT03391765Phase 2Results posted
- Relapse Prevention Study of Pimavanserin in Dementia-related PsychosisCompletedNCT03325556Phase 3Results posted
- Study of BIIB092 in Participants With Progressive Supranuclear PalsyTerminatedNCT03068468Phase 2Results posted
- A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP)TerminatedNCT02985879Phase 2Results posted
- Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy VolunteersCompletedNCT02167594Phase 1Results posted
- Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear PalsyCompletedNCT01537549Phase 1/2Results posted
- A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal DegenerationCompletedNCT00703677Phase 1/2Results posted
- Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)CompletedNCT00382824Not applicableResults posted
- First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the BrainCompletedNCT07348276Early Phase 1
- Neuroinflammation in FTLDActive, not recruitingNCT06870838
- Art Therapy in Progressive Supranuclear PalsyActive, not recruitingNCT06588673Not applicable
- Biomarkers in Parkinsonian SyndromesActive, not recruitingNCT06501469
- A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP)Active, not recruitingNCT06355531Phase 2
- Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011CompletedNCT06235775Phase 2
- Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register StudyActive, not recruitingNCT06209515
- AMX0035 and Progressive Supranuclear PalsyCompletedNCT06122662Phase 2/3
- A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) SyndromesActive, not recruitingNCT05956834
- Automated Imaging Differentiation of ParkinsonismActive, not recruitingNCT05913687
- Speech Accessibility ProjectCompletedNCT05889260
- Unstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian DisordersStatus unknownNCT05638477Not applicable
- Study of Comprehensive ANd Multimodal Marker-based Cohort of Progressive Supranuclear Palsy(PSP)Status unknownNCT05579301
- Personalized Parkinson Project PSP CohortCompletedNCT05501431
- Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL)Active, not recruitingNCT05459753Not applicable
- Tau Protein and SV2a Imaging in Patients With Tau Protein-related DiseasesStatus unknownNCT05260151
- Community Outreach for Palliative Engagement -- Parkinson DiseaseActive, not recruitingNCT05222386Not applicable
- Test-retest Study With [18F]PI-2620 in PSP-RS and NDCCompletedNCT05187546Phase 1
- Proactive and Integrated Management and Empowerment in Parkinson's Disease (PRIME-UK): A New Model of Care (PRIME-RCT)CompletedNCT05127057Not applicable
- Optimization of Morphomer-based Alpha-synuclein PET TracersCompletedNCT05067192
- Evaluation of [18F]APN-1607 as a PET BiomarkerCompletedNCT05005819Phase 1
- A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)CompletedNCT04993768Phase 2
- RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSYStatus unknownNCT04937530Phase 2
- Complex Eye Movements in Parkinson's Disease and Related Movement DisordersCompletedNCT04925622
- tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility StudyWithdrawnNCT04883229Not applicable
- Application of Machine Learning Method in Validation of Screening Cognitive Test for ParkinsonismsCompletedNCT04858893
- Subcutaneous Apomorphine in the Treatment of Progressive Supranuclear Palsy and Cortico Basal Degeneration (APOPARKA)CompletedNCT04786158
- Rho Kinase (ROCK) Inhibitor in Tauopathies - 1Status unknownNCT04734379Phase 2
- Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific ActivityCompletedNCT04715750Phase 1
- The MOTIVE-PSP Initiative (Progressive Supranuclear Palsy)Status unknownNCT04691635
- A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear PalsyActive, not recruitingNCT04658199Phase 1
- Efficacy and Safety of Transcranial dIrect Current stiMulation (tDCS) in Progressive Supranuclear Palsy (PSP) (STIM-PSP)CompletedNCT04655079Not applicable
- Mobility in Atypical Parkinsonism: a Trial of PhysiotherapyCompletedNCT04608604Not applicable
- Image Characteristic and Longitudinal Follow up of 18F-PMPBB3 (APN-1607) PET for Progressive Supranuclear PalsyStatus unknownNCT04541836
- Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear PalsyCompletedNCT04539041Phase 1
- Misfolded Proteins in the Skin of People With Parkinson's Disease and Other ParkinsonismCompletedNCT04518059
- The Study to Evaluate the Safety and Efficacy of Spinal Cord Stimulation on Progressive Supranuclear PalsyTerminatedNCT04367116Not applicable
- Evaluation of Tolfenamic Acid in Individuals With PSP at 12-WeeksStatus unknownNCT04253132Phase 1/2